AKT1 and breast cancer: Gargini et al. reported that ablation of AKT1 and to a minor degree of AKT2 resulted in a loss of the stem cell phenotype of breast cancer stem cells through the induction of a mesenchymal-epithelial transition by increasing Bim levels via regulation of FoxO3.